Discover and read the best of Twitter Threads about #EuroPace
Most recents (3)
#EHRAtopicweek on device implantation techniques & peri-operative management
General considerations: Management of anticoagulation
1/4
#EHRA_ESC
General considerations: Management of anticoagulation
1/4
#EHRA_ESC
#EHRAtopicweek
BRUISE CONTROL:
A clinically significant pocket hematoma is an independent risk factor for subsequent device infection (HR 7.7).
@JACCJournals
bit.ly/3ocT2JU
2/4
BRUISE CONTROL:
A clinically significant pocket hematoma is an independent risk factor for subsequent device infection (HR 7.7).
@JACCJournals
bit.ly/3ocT2JU
2/4
#EHRAtopicweek
BRUISE CONTROL-2
- suggesting that either stopping or continuing non-vitamin K antagonist oral anticoagulants might be reasonable at the time of device implantation.
#EHJ @ESC_Journal bit.ly/3L1kyE8
3/4
BRUISE CONTROL-2
- suggesting that either stopping or continuing non-vitamin K antagonist oral anticoagulants might be reasonable at the time of device implantation.
#EHJ @ESC_Journal bit.ly/3L1kyE8
3/4
A must-read!
#EPeeps #Europace - Supplement Issue
A dedication to Prof Harry Crijns
🙏
“#Innovations and #Paradigm Shifts in #AFib Management”
Now online👉🏻bit.ly/3sbeiyJ
@EHRAPresident @escardio @ESC_Journals
@GerdHindricks @ABollmannMD
@kvernooy @JordiHeijman
#EPeeps #Europace - Supplement Issue
A dedication to Prof Harry Crijns
🙏
“#Innovations and #Paradigm Shifts in #AFib Management”
Now online👉🏻bit.ly/3sbeiyJ
@EHRAPresident @escardio @ESC_Journals
@GerdHindricks @ABollmannMD
@kvernooy @JordiHeijman
Role of #genetics in atrial fibrillation management
By M Rienstra, @patrick_ellinor et al.
👉🏻 bit.ly/3s3rgP7
By M Rienstra, @patrick_ellinor et al.
👉🏻 bit.ly/3s3rgP7
Paradigm shifts in electrophysiological mechanisms of atrial fibrillation
By U Schotten, @stefzeemering et al.
bit.ly/3fVrVjj
By U Schotten, @stefzeemering et al.
bit.ly/3fVrVjj
This population-based, multicentre, 10-year study of the use of oral #anticoagulants for #stroke prophylaxis for ~0.5M patients with #AFib found that their prescription for patients with #AF at high risk of stroke increased by nearly 60%.
Between 2009 & 2018, 3352 individual General Practices provided a total of 5968 uploads into the GRASP-AF database. From the first upload per General Practice, there were an estimated 450 518 patients with #AFib from a total of 24 644 210 people.
Over the study period the prevalence of AF was 1.8% [95% CI 1.7–1.9%], which increased from 1.6% (1.5–1.7%) in 2009 to 2.4% (2.3–2.5%) in 2018 (P-trend < 0.001).
